Some of our cancer centers are experiencing issues.  View More Important Notifications x
texas oncology more breakthroughs. more victories



Texas Oncology to Expand San Antonio Research Program as Dr. Anthony Tolcher Joins Practice

Texas Oncology announced today that world renowned cancer researcher Anthony Tolcher, M.D. has joined Texas Oncology-San Antonio Medical Center. Tolcher will help advance and expand Texas Oncology’s existing comprehensive research and clinical trials program, which currently includes more than 2,000 patients annually statewide participating in more than 150 open trials at any given time. Tolcher is a co-founder of San Antonio-based South Texas Accelerated Research Therapeutics (START), a leader in Phase 1 medical oncology clinical trials.

“At Texas Oncology, providing our patients access to the most advanced treatment is a priority, including participating in research and clinical trials. As a recognized leader in connecting patients to life saving treatment innovations, Dr. Tolcher will be key to our commitment to growing the research program in our community-based practice,” said Dr. Steve Paulson, chairman and president of Texas Oncology. 

Tolcher is a graduate of the University of British Columbia in Vancouver, Canada. Following residencies at the University of Toronto and the University of British Columbia, he was a research fellow at the National Cancer Institute in Bethesda, Md. Before co-founding START, he was director of clinical research at Cancer Therapy and Research Center in San Antonio. 

Tolcher’s accolades include fellowships from the National Institutes of Health and the Royal College of Physicians in Canada. He is a Fellow of the American Society of Clinical Oncology, Past Chairman of the Experimental Scientific Review Committee, and member of the Cancer Education Committees. Tolcher also is a reviewer for multiple scientific journals, and he has authored over 100 peer-reviewed publications, 26 conference proceedings, and five book chapters. He was instrumental in the founding of the San Antonio 1000 Cancer Genome Project which will continue to benefit cancer genomics and the patients of San Antonio.

“Texas Oncology’s pioneering approach to delivering high quality, innovative treatment to patients in communities, close to needed support, while also being committed to discovering new treatment breakthroughs perfectly aligns with my passion for research. I am excited to join this dedicated team of cancer fighters,” said Tolcher.

Tolcher will be based at the new Texas Oncology-San Antonio Medical Center location at 5206 Research Drive.

About Texas Oncology

Texas Oncology is an independent private practice with more than 490 physicians and 210 locations across the state. Meeting the oncology needs of Texans for more than 35 years, the practice includes Texas Center for Proton Therapy, Texas Breast Specialists, Texas Oncology Surgical Specialists, and Texas Center for Interventional Surgery. As a lead participant in US Oncology Research, Texas Oncology played a role in the development of more than 98 FDA-approved therapies, about one-third of all cancer therapies approved to date. For more information, visit

Related Physicians

Related Cancer Centers